col 2 Search Results


96
Rockland Immunochemicals anti collagen type ii rabbit antibody
Anti Collagen Type Ii Rabbit Antibody, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti collagen type ii rabbit antibody/product/Rockland Immunochemicals
Average 96 stars, based on 1 article reviews
anti collagen type ii rabbit antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

93
Addgene inc herpes simplex virus thymidine kinase allele
Herpes Simplex Virus Thymidine Kinase Allele, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/herpes simplex virus thymidine kinase allele/product/Addgene inc
Average 93 stars, based on 1 article reviews
herpes simplex virus thymidine kinase allele - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Bioworld Antibodies primary antibodies against col2
Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and <t>COL2</t> was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Primary Antibodies Against Col2, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against col2/product/Bioworld Antibodies
Average 90 stars, based on 1 article reviews
primary antibodies against col2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Artialis Inc degradation [coll2-1]
Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and <t>COL2</t> was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Degradation [Coll2 1], supplied by Artialis Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/degradation [coll2-1]/product/Artialis Inc
Average 90 stars, based on 1 article reviews
degradation [coll2-1] - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Merck KGaA collagen type ii 6b3 antibody
Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and <t>COL2</t> was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Collagen Type Ii 6b3 Antibody, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/collagen type ii 6b3 antibody/product/Merck KGaA
Average 90 stars, based on 1 article reviews
collagen type ii 6b3 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA type ii collagen (col2) antibody
Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and <t>COL2</t> was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Type Ii Collagen (Col2) Antibody, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/type ii collagen (col2) antibody/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
type ii collagen (col2) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jackson Laboratory col2.3creer
Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and <t>COL2</t> was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Col2.3creer, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col2.3creer/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
col2.3creer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Qiagen col2a1-promoter luciferase reporter plasmid
Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and <t>COL2</t> was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Col2a1 Promoter Luciferase Reporter Plasmid, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col2a1-promoter luciferase reporter plasmid/product/Qiagen
Average 90 stars, based on 1 article reviews
col2a1-promoter luciferase reporter plasmid - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
IBEX Technologies antibodies against c1,2c (col2 3⁄4 cshort) neoepitope
Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and <t>COL2</t> was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group
Antibodies Against C1,2c (Col2 3⁄4 Cshort) Neoepitope, supplied by IBEX Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against c1,2c (col2 3⁄4 cshort) neoepitope/product/IBEX Technologies
Average 90 stars, based on 1 article reviews
antibodies against c1,2c (col2 3⁄4 cshort) neoepitope - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GenScript corporation col2 peptides
Effects of TLR2-blockade on expression levels of chondrocyte development and cartilage degradation-related genes in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or <t>Col2</t> peptide in the presence of 20 ng/ml of anti-TLR2 antibodies and expression levels of chondrocyte development and cartilage degradation-related genes were determined by quantitative realtime PCR. Comparison of expression levels of chondrocyte differentiation and development (HOXA11, SOX5 and RUNX2) ( A ), cartilagenous matrix (COL2A1) ( B ), and cartilage degradation (IL-6) ( C ) -related genes from chondrocytes stimulated with IFNγ and PG peptides, aggrecan 32-mer peptide and Col2 peptide with and without anti-TLR2 treated chondrocytes were normalized to GAPDH and interpreted as relative expression levels (fold change) (Y-axis). Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).
Col2 Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col2 peptides/product/GenScript corporation
Average 90 stars, based on 1 article reviews
col2 peptides - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Coriell Institute for Medical Research col2-pathy hdfs
Effects of TLR2-blockade on expression levels of chondrocyte development and cartilage degradation-related genes in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or <t>Col2</t> peptide in the presence of 20 ng/ml of anti-TLR2 antibodies and expression levels of chondrocyte development and cartilage degradation-related genes were determined by quantitative realtime PCR. Comparison of expression levels of chondrocyte differentiation and development (HOXA11, SOX5 and RUNX2) ( A ), cartilagenous matrix (COL2A1) ( B ), and cartilage degradation (IL-6) ( C ) -related genes from chondrocytes stimulated with IFNγ and PG peptides, aggrecan 32-mer peptide and Col2 peptide with and without anti-TLR2 treated chondrocytes were normalized to GAPDH and interpreted as relative expression levels (fold change) (Y-axis). Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).
Col2 Pathy Hdfs, supplied by Coriell Institute for Medical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col2-pathy hdfs/product/Coriell Institute for Medical Research
Average 90 stars, based on 1 article reviews
col2-pathy hdfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Genetica Inc col2-3/4cshort
Effects of TLR2-blockade on expression levels of chondrocyte development and cartilage degradation-related genes in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or <t>Col2</t> peptide in the presence of 20 ng/ml of anti-TLR2 antibodies and expression levels of chondrocyte development and cartilage degradation-related genes were determined by quantitative realtime PCR. Comparison of expression levels of chondrocyte differentiation and development (HOXA11, SOX5 and RUNX2) ( A ), cartilagenous matrix (COL2A1) ( B ), and cartilage degradation (IL-6) ( C ) -related genes from chondrocytes stimulated with IFNγ and PG peptides, aggrecan 32-mer peptide and Col2 peptide with and without anti-TLR2 treated chondrocytes were normalized to GAPDH and interpreted as relative expression levels (fold change) (Y-axis). Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).
Col2 3/4cshort, supplied by Genetica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/col2-3/4cshort/product/Genetica Inc
Average 90 stars, based on 1 article reviews
col2-3/4cshort - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and COL2 was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group

Journal: Arthritis Research & Therapy

Article Title: Ketogenic diet ameliorates inflammation by inhibiting the NLRP3 inflammasome in osteoarthritis

doi: 10.1186/s13075-022-02802-0

Figure Lengend Snippet: Evaluation of cartilage degeneration in the knee joint. A Expression of MMP13 and COL2 was detected using immunohistochemistry. Scale bar, 20 μm. B , C Quantitative analysis of the expression of MMP13 and COL2 in immunohistochemical results. n = 3 per group, with a total of 9 animals used. # P < 0.05 versus the sham group, * P < 0.05 versus the SD group

Article Snippet: The specimens were incubated with primary antibodies against NLRP3 (1:100, Abcam, MA, USA), ASC (1:100, Abcam, MA, USA), Caspase-1 p20 (1:100, Bioworld Technology, MN, USA), IL-1β (1:100, Bioworld Technology, MN, USA), IL-18 (1:100, Bioworld Technology, MN, USA), MMP13 (1:100, Abcam, MA, USA), and COL2 (1:100, Bioworld Technology, MN, USA) at 4 °C overnight.

Techniques: Expressing, Immunohistochemistry, Immunohistochemical staining

Effects of TLR2-blockade on expression levels of chondrocyte development and cartilage degradation-related genes in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or Col2 peptide in the presence of 20 ng/ml of anti-TLR2 antibodies and expression levels of chondrocyte development and cartilage degradation-related genes were determined by quantitative realtime PCR. Comparison of expression levels of chondrocyte differentiation and development (HOXA11, SOX5 and RUNX2) ( A ), cartilagenous matrix (COL2A1) ( B ), and cartilage degradation (IL-6) ( C ) -related genes from chondrocytes stimulated with IFNγ and PG peptides, aggrecan 32-mer peptide and Col2 peptide with and without anti-TLR2 treated chondrocytes were normalized to GAPDH and interpreted as relative expression levels (fold change) (Y-axis). Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Journal: Scientific Reports

Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media

doi: 10.1038/s41598-024-68404-9

Figure Lengend Snippet: Effects of TLR2-blockade on expression levels of chondrocyte development and cartilage degradation-related genes in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or Col2 peptide in the presence of 20 ng/ml of anti-TLR2 antibodies and expression levels of chondrocyte development and cartilage degradation-related genes were determined by quantitative realtime PCR. Comparison of expression levels of chondrocyte differentiation and development (HOXA11, SOX5 and RUNX2) ( A ), cartilagenous matrix (COL2A1) ( B ), and cartilage degradation (IL-6) ( C ) -related genes from chondrocytes stimulated with IFNγ and PG peptides, aggrecan 32-mer peptide and Col2 peptide with and without anti-TLR2 treated chondrocytes were normalized to GAPDH and interpreted as relative expression levels (fold change) (Y-axis). Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or Col2 peptides (GenScript) for 30 min with or without anti-TLR2 antibodies or LCM- LS- B60.

Techniques: Expressing, Comparison

Effects of TLR2 blockade on cartilage-degrading enzyme production in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or Col2 peptide in the presence of 20 ng/ml of anti-TLR2 antibodies. Cartilage degrading- enzymes (MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5) and IL-6 production were determined by ELISA. ( A ) Bar graphs showing comparison of MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5 production from IFNγ and PG peptide, aggrecan 32-mer peptide and Col2 peptide stimulation with ( +) and without (-) anti-TLR2 antibodies. Y-axis represents cartilage-degrading enzyme concentrations (pg/ml). ( B ) Bar graphs showing percentage of inhibition of MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5 production after TLR2 blockade in each stimulation condition. ( C ) Bar graph showing comparison of IL-6 production from IFNγ and PG peptide stimulation with ( +) and without (-) anti-TLR2 antibody. Y-axis represents IL-6 concentration (pg/ml). ( D ) Bar graph showing the percentage of inhibition of IL-6 production after TLR2 blocking in IFNγ and PG peptide-stimulated chondrocytes. Data was shown as mean ± SEM and significant difference of cartilage degrading factor production was calculated by two-way ANOVA with bonferroni post hoc test, while significant difference of percentage of inhibition was calculated by one-way ANOVA with post-hoc Turky HSD (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Journal: Scientific Reports

Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media

doi: 10.1038/s41598-024-68404-9

Figure Lengend Snippet: Effects of TLR2 blockade on cartilage-degrading enzyme production in PG peptide-stimulated chondrocytes. Knee OA chondrocytes (N = 10) were treated with 50 ng/ml of IFNγ and 10 µg/ml of PG peptides (p16-31, p263-280 or p2379-2394), the aggrecan 32-mer peptide or Col2 peptide in the presence of 20 ng/ml of anti-TLR2 antibodies. Cartilage degrading- enzymes (MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5) and IL-6 production were determined by ELISA. ( A ) Bar graphs showing comparison of MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5 production from IFNγ and PG peptide, aggrecan 32-mer peptide and Col2 peptide stimulation with ( +) and without (-) anti-TLR2 antibodies. Y-axis represents cartilage-degrading enzyme concentrations (pg/ml). ( B ) Bar graphs showing percentage of inhibition of MMP-1, MMP-9, MMP-13, ADAMTS-4 and ADAMTS-5 production after TLR2 blockade in each stimulation condition. ( C ) Bar graph showing comparison of IL-6 production from IFNγ and PG peptide stimulation with ( +) and without (-) anti-TLR2 antibody. Y-axis represents IL-6 concentration (pg/ml). ( D ) Bar graph showing the percentage of inhibition of IL-6 production after TLR2 blocking in IFNγ and PG peptide-stimulated chondrocytes. Data was shown as mean ± SEM and significant difference of cartilage degrading factor production was calculated by two-way ANOVA with bonferroni post hoc test, while significant difference of percentage of inhibition was calculated by one-way ANOVA with post-hoc Turky HSD (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or Col2 peptides (GenScript) for 30 min with or without anti-TLR2 antibodies or LCM- LS- B60.

Techniques: Enzyme-linked Immunosorbent Assay, Comparison, Inhibition, Concentration Assay, Blocking Assay

Inhibition effect of Lactobacillus- conditioned medium on cartilage degraded mediators released from chondrocytes after IFNγ with PG peptides treatment. Chondrocytes isolated from OA patients (N = 4) were treated with 10% of Lactobacillus -conditioned medium (LCM), L. gasseri- L10 (LG-L10), L. rhamnosus-L34 (LR-L34), L. casei -L39 (LC-L39), L. salivarius -B60 (LS-B60) and L. plantarum -XB7 (LP-XB7) before stimulating with IFNγ and either PG peptides (p16-31, p263-280 and p2379-2394) or control peptides (32-mer and Col2). The cultured medium was collected for cartilage degraded mediators measurement by ELISA. ( A ) Comparison of MMP-1, MMP-9, MMP-13, ADAMTS-4, ADAMTS-5 and IL-6 production from IFNγ and PG peptides stimulated chondrocytes between LCM-treated and untreated conditions ( B ) Bar graphs show the MMP-1 and MMP-13 production in 10% LCM-treated chondrocytes (without IFNγ and PG peptides stimulation) compared with that of chondrocytes treated with 10% of heated LCM. ( C ) Bar graphs show the MMP-1 and MMP-13 production in 10% LCM-treated chondrocytes (without IFNγ and PG peptides stimulation) compared with that of chondrocytes treated with 10% of proteinase K-treated LCM. Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with Bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Journal: Scientific Reports

Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media

doi: 10.1038/s41598-024-68404-9

Figure Lengend Snippet: Inhibition effect of Lactobacillus- conditioned medium on cartilage degraded mediators released from chondrocytes after IFNγ with PG peptides treatment. Chondrocytes isolated from OA patients (N = 4) were treated with 10% of Lactobacillus -conditioned medium (LCM), L. gasseri- L10 (LG-L10), L. rhamnosus-L34 (LR-L34), L. casei -L39 (LC-L39), L. salivarius -B60 (LS-B60) and L. plantarum -XB7 (LP-XB7) before stimulating with IFNγ and either PG peptides (p16-31, p263-280 and p2379-2394) or control peptides (32-mer and Col2). The cultured medium was collected for cartilage degraded mediators measurement by ELISA. ( A ) Comparison of MMP-1, MMP-9, MMP-13, ADAMTS-4, ADAMTS-5 and IL-6 production from IFNγ and PG peptides stimulated chondrocytes between LCM-treated and untreated conditions ( B ) Bar graphs show the MMP-1 and MMP-13 production in 10% LCM-treated chondrocytes (without IFNγ and PG peptides stimulation) compared with that of chondrocytes treated with 10% of heated LCM. ( C ) Bar graphs show the MMP-1 and MMP-13 production in 10% LCM-treated chondrocytes (without IFNγ and PG peptides stimulation) compared with that of chondrocytes treated with 10% of proteinase K-treated LCM. Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with Bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or Col2 peptides (GenScript) for 30 min with or without anti-TLR2 antibodies or LCM- LS- B60.

Techniques: Inhibition, Isolation, Control, Cell Culture, Enzyme-linked Immunosorbent Assay, Comparison

Effects of TLR2 blockade and Lactobacillus- conditioned media treatment on intracellular signaling activation in PG peptide-stimulated chondrocytes. Chondrocytes isolated from OA patients (N = 5) were treated with 20 μg/ml of anti-TLR2 antibodies or 10% of LCM, L. salivarius -B60 for 1 h before stimulating with IFNγ and PG peptides (p16-31, p263-280 and p2379-2394) or control peptides (32-mer and Col2 peptides). Intracellular phosphorylated proteins; p-STAT3, p-IkBα, p-ERK1/2, p-p38 and p-MAPK9 (JNK2) were determined by flow cytometry. ( A ) Bar graph showing the fold change of mean fluorescent intensity of phosphorylated proteins of stimulated chondrocyte which was divided by that of unstimulated chondrocytes. Statistical significance was calculated by one-way ANOVA with post-hoc Turky HSD. ( B ) Comparison of mean fluorescence intensity (MFI) of phosphorylated protein expression after stimulating with IFNγ and PG peptides between no blocking and anti-TLR2 antibody treatment (upper panel) or between no blocking and L. salivarius -B60 LCM treatment in each individual. Statistical significance was calculated by paired-T test. ( C ) Bar graphs showing the comparison of percentage of phosphorylated protein- expressing chondrocytes in no blocking, anti-TLR2 antibody treatment and L. salivarius -B60 LCM treatment conditions after stimulation with IFNγ and PG peptides or control peptides. Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with Bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Journal: Scientific Reports

Article Title: Catabolic mediators from TLR2-mediated proteoglycan aggrecan peptide-stimulated chondrocytes are reduced by Lactobacillus -conditioned media

doi: 10.1038/s41598-024-68404-9

Figure Lengend Snippet: Effects of TLR2 blockade and Lactobacillus- conditioned media treatment on intracellular signaling activation in PG peptide-stimulated chondrocytes. Chondrocytes isolated from OA patients (N = 5) were treated with 20 μg/ml of anti-TLR2 antibodies or 10% of LCM, L. salivarius -B60 for 1 h before stimulating with IFNγ and PG peptides (p16-31, p263-280 and p2379-2394) or control peptides (32-mer and Col2 peptides). Intracellular phosphorylated proteins; p-STAT3, p-IkBα, p-ERK1/2, p-p38 and p-MAPK9 (JNK2) were determined by flow cytometry. ( A ) Bar graph showing the fold change of mean fluorescent intensity of phosphorylated proteins of stimulated chondrocyte which was divided by that of unstimulated chondrocytes. Statistical significance was calculated by one-way ANOVA with post-hoc Turky HSD. ( B ) Comparison of mean fluorescence intensity (MFI) of phosphorylated protein expression after stimulating with IFNγ and PG peptides between no blocking and anti-TLR2 antibody treatment (upper panel) or between no blocking and L. salivarius -B60 LCM treatment in each individual. Statistical significance was calculated by paired-T test. ( C ) Bar graphs showing the comparison of percentage of phosphorylated protein- expressing chondrocytes in no blocking, anti-TLR2 antibody treatment and L. salivarius -B60 LCM treatment conditions after stimulation with IFNγ and PG peptides or control peptides. Data was shown as mean ± SEM and statistical significance was calculated by two-way ANOVA with Bonferroni post hoc test (*, p < 0.0500; **, p < 0.0100; ***, p < 0.0010; ****, p < 0.0001).

Article Snippet: Isolated chondrocytes were cultured in a 48-well plate (1 × 10 5 cells/well) and stimulated with 50 ng/ml IFNγ (R&D System) with either 10 μg/ml p16-31, p263-280, p2379-2394, 32-mer or Col2 peptides (GenScript) for 30 min with or without anti-TLR2 antibodies or LCM- LS- B60.

Techniques: Activation Assay, Isolation, Control, Flow Cytometry, Comparison, Fluorescence, Expressing, Blocking Assay